Expert Opinion on Pharmacotherapy, Volume 25, Issue 7 (2024)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Expert Opinion on Pharmacotherapy, Volume 25, Issue 7 (2024)

See all volumes and issues
Volume 25, 2024 Vol 24, 2023 Vol 23, 2022 Vol 22, 2021 Vol 21, 2020 Vol 20, 2019 Vol 19, 2018 Vol 18, 2017 Vol 17, 2016 Vol 16, 2015 Vol 15, 2014 Vol 14, 2013 Vol 13, 2012 Vol 12, 2011 Vol 11, 2010 Vol 10, 2009 Vol 9, 2008 Vol 8, 2007 Vol 7, 2006 Vol 6, 2005 Vol 5, 2004 Vol 4, 2003 Vol 3, 2002 Vol 2, 2001 Vol 1, 1999-2000
Download citations Download PDFs Download issue

Drug Evaluation

Review Article
Elinzanetant, a new combined neurokinin-1/-3 receptor antagonist for the treatment of postmenopausal vasomotor symptoms
Marlene Hager, Tal Goldstein, Victoria Fitz & Johannes Ott
Pages: 783-789
Published online: 13 Jun 2024
AbstractforElinzanetant, a new combined neurokinin-1/-3 receptor antagonist for the treatment of postmenopausal vasomotor symptoms | Full Text | References | PDF (348.1 KB) | EPUB
  • 352 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Review Article
Review of valiltramiprosate (ALZ-801) for the treatment of Alzheimer’s disease: a novel small molecule with disease modifying potential
Daniel Lee, Inga M. Antonsdottir, Emily D. Clark & Anton P. Porsteinsson
Pages: 791-799
Published online: 30 May 2024
AbstractforReview of valiltramiprosate (ALZ-801) for the treatment of Alzheimer’s disease: a novel small molecule with disease modifying potential | Full Text | References | PDF (359.3 KB) | EPUB
  • 100 Views
  • 0 CrossRef citations
  • 0Altmetric

Review

Review Article
Oral glucagon-like peptide-1 receptor agonists and combinations of entero-pancreatic hormones as treatments for adults with type 2 diabetes: where are we now?
Prathima Gogineni, Eka Melson, Dimitris Papamargaritis & Melanie Davies
Pages: 801-818
Published online: 22 May 2024
AbstractforOral glucagon-like peptide-1 receptor agonists and combinations of entero-pancreatic hormones as treatments for adults with type 2 diabetes: where are we now? | Full Text | References | PDF (2.4 MB) | EPUB
  • 2162 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Review Article
Juxtaglomerular apparatus-mediated homeostatic mechanisms: therapeutic implication for chronic kidney disease
Eiji Higashihara, Takeo Harada & Hiroshi Fukuhara
Pages: 819-832
Published online: 22 May 2024
AbstractforJuxtaglomerular apparatus-mediated homeostatic mechanisms: therapeutic implication for chronic kidney disease | Full Text | References | PDF (9.2 MB) | EPUB
  • 515 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Review Article
Revolutionizing hepatitis C treatment: next-gen direct-acting antivirals
Krystyna Dobrowolska, Michał Brzdęk, Piotr Rzymski, Robert Flisiak, Małgorzata Pawłowska, Jakub Janczura, Kinga Brzdęk & Dorota Zarębska-Michaluk
Pages: 833-852
Published online: 27 May 2024
AbstractforRevolutionizing hepatitis C treatment: next-gen direct-acting antivirals | Full Text | References | PDF (2.5 MB) | EPUB | Supplemental
  • 113 Views
  • 0 CrossRef citations
  • 0Altmetric
Review Article
Recent advances in pharmacological management of attention-deficit/hyperactivity disorder: moving beyond stimulants
Ann Childress
Pages: 853-866
Published online: 27 May 2024
AbstractforRecent advances in pharmacological management of attention-deficit/hyperactivity disorder: moving beyond stimulants | Full Text | References | PDF (413.6 KB) | EPUB
  • 188 Views
  • 0 CrossRef citations
  • 0Altmetric
Review Article
Promising immunomodulators for management of substance and alcohol use disorders
Amanda M. Acuña, Connor Park, Jonna M. Leyrer-Jackson & M. Foster Olive
Pages: 867-884
Published online: 31 May 2024
AbstractforPromising immunomodulators for management of substance and alcohol use disorders | Full Text | References | PDF (434.7 KB) | EPUB
  • 115 Views
  • 0 CrossRef citations
  • 0Altmetric
Review Article
Advances in the pharmacological management of cutaneous T-cell lymphoma
Gabriele Roccuzzo, Andrea Roggo, Egle Ramelyte, Sara Marchisio, Chiara Astrua, Simone Ribero, Julia Scarisbrick, Paolo Fava & Pietro Quaglino
Pages: 885-894
Published online: 03 Jun 2024
AbstractforAdvances in the pharmacological management of cutaneous T-cell lymphoma | Full Text | References | PDF (298.4 KB) | EPUB
  • 106 Views
  • 0 CrossRef citations
  • 0Altmetric
Review Article
Navigating the liver landscape: upcoming pharmacotherapies for primary sclerosing cholangitis
Hoang Nam Pham, Linh Pham & Keisaku Sato
Pages: 895-906
Published online: 31 May 2024
AbstractforNavigating the liver landscape: upcoming pharmacotherapies for primary sclerosing cholangitis | Full Text | References | PDF (1.1 MB) | EPUB
  • 82 Views
  • 0 CrossRef citations
  • 0Altmetric
Review Article
Exploring pharmacological interventions in benign prostate hyperplasia: the role of cost-effectiveness analysis in daily practice and future directions
Murtadha Almusafer, Yash Narayan, Ijeoma Nnorom, Sourabh Karna, Antigoni Katsouri, Giorgio Ivan Russo, Afonso Morgado, Evangelos N Symeonidis, Noor Buchholz, Athanasios Papatsoris & Georgios Tsampoukas
Pages: 907-914
Published online: 03 Jun 2024
AbstractforExploring pharmacological interventions in benign prostate hyperplasia: the role of cost-effectiveness analysis in daily practice and future directions | Full Text | References | PDF (261.4 KB) | EPUB
  • 44 Views
  • 0 CrossRef citations
  • 0Altmetric
Review Article
Promising therapies for adults with symptomatic obstructive hypertrophic cardiomyopathy: 2023 and beyond
Andrew Gaballa, Shada Jadam & Milind Y. Desai
Pages: 915-924
Published online: 04 Jun 2024
AbstractforPromising therapies for adults with symptomatic obstructive hypertrophic cardiomyopathy: 2023 and beyond | Full Text | References | PDF (3.7 MB) | EPUB
  • 99 Views
  • 0 CrossRef citations
  • 0Altmetric

Meta-analysis

Review Article
Effect of ipragliflozin on liver enzymes in type 2 diabetes mellitus: a meta-analysis of randomized controlled trials
Rizwana Parveen, Shadan Hussain, Sparsh Saini, Parvej Khan, Nilanjan Saha & Nidhi
Pages: 925-935
Published online: 31 May 2024
AbstractforEffect of ipragliflozin on liver enzymes in type 2 diabetes mellitus: a meta-analysis of randomized controlled trials | Full Text | References | PDF (7.2 MB) | EPUB | Supplemental
  • 58 Views
  • 0 CrossRef citations
  • 0Altmetric

Original Research

Article
Empagliflozin increases plasma levels of citrulline, histidine, and α-aminobutyric acid in patients with type 2 diabetes: effects of a sodium-glucose co-transporter 2 inhibitor on the plasma amino acid profile
Teruo Jojima, Shintaro Sakurai, Haruka Kishi, Kananko Kato, Toshie Iijima, Takuya Tomaru, Isao Usui & Yoshimasa Aso
Pages: 937-944
Published online: 04 Jun 2024
AbstractforEmpagliflozin increases plasma levels of citrulline, histidine, and α-aminobutyric acid in patients with type 2 diabetes: effects of a sodium-glucose co-transporter 2 inhibitor on the plasma amino acid profile | Full Text | References | PDF (399.8 KB) | EPUB | Supplemental
  • 46 Views
  • 0 CrossRef citations
  • 0Altmetric

Explore articles

Explore the most recently published articles

Advances in the pharmacological management of bronchopulmonary dysplasia: an update of the literature
Tolu Oluwole-Ojo et al.
Review Article | Published online: 23 Jul 2024
Clinical challenges and considerations in pharmacotherapy of osteoporosis due to menopause
Santiago Palacios et al.
Review Article | Published online: 23 Jul 2024
A spotlight on using HIF-PH inhibitors in renal anemia
Motoki Odawara et al.
Report | Published online: 17 Jul 2024
Considerations when treating influenza infections with oseltamivir
Chunping Gu et al.
Review Article | Published online: 15 Jul 2024
View all latest articles